Lionco Pharmaceutical Group Co.,Ltd.

Lionco Pharmaceutical Group Co.,Ltd.verified

603669.SS

Price:

$5.07

Market Cap:

$3.66B

Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China. The company offers nutrition, antimicrobial, antiviral, digestion, cardiovascular, detoxification, anti-tumor, and other products. It also operates research institutes that specialize in the research of chemical drugs, natural medicines, and biological drugs. Lionco Pharmaceutical Group Co., Ltd. was founded in 2003 and is based in Shannan, China.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2015-05-28

Stock Exchange

SHH

Ticker

603669.SS

The ROE as of December 2025 (TTM) for Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) is -15.83%

According to Lionco Pharmaceutical Group Co.,Ltd.’s latest financial reports and current stock price. The company's current ROE is -15.83%. This represents a change of 307.62% compared to the average of -3.88% of the last 4 quarters.

Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) Historical ROE (quarterly & annually)

How has 603669.SS ROE performed in the past?

The mean historical ROE of Lionco Pharmaceutical Group Co.,Ltd. over the last ten years is 3.24%. The current -15.83% ROE has changed -589.35% with respect to the historical average. Over the past ten years (40 quarters), 603669.SS's ROE was at its highest in in the September 2018 quarter at 7.12%. The ROE was at its lowest in in the December 2022 quarter at -11.12%.

Quarterly (TTM)
Annual

Average

3.24%

Median

11.60%

Minimum

-17.24%

Maximum

15.34%

Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) ROE by Quarter and Year

Discovering the peaks and valleys of Lionco Pharmaceutical Group Co.,Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 15.72%

Maximum Annual ROE = 15.34%

Minimum Annual Increase = -481.72%

Minimum Annual ROE = -17.24%

Quarterly (TTM)
Annual
YearROEChange
2024-16.99%4.40%
2023-16.27%-5.64%
2022-17.24%-481.72%
20214.52%-58.24%
202010.82%-29.50%
201915.34%15.72%
201813.26%7.00%
201712.39%-5.85%
201613.16%-1.56%
201513.37%-66.62%

Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) Average ROE

How has 603669.SS ROE performed in the past?

The current ROE of Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

-16.83%

5-year avg

-7.03%

10-year avg

3.24%

Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) ROE vs. Peers

How is 603669.SS’s ROE compared to its peers?

Lionco Pharmaceutical Group Co.,Ltd.’s ROE is greater than Honz Pharmaceutical Co., Ltd. (-17.26%), greater than Zhongzhu Healthcare Holding Co.,Ltd (-32.45%), greater than Huaren Pharmaceutical Co., Ltd. (-106.15%), greater than Harbin Medisan Pharmaceutical Co., Ltd. (-9.30%), less than Nanjing Well Pharmaceutical Group Co.,Ltd. (8.53%), less than Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (17.53%), less than ZhuZhou QianJin Pharmaceutical Co.,Ltd (10.08%), greater than Wuhan Hiteck Biological Pharma Co.,Ltd (-8.03%), greater than Guizhou Yibai Pharmaceutical Co., Ltd. (-9.53%), less than Tibet AIM Pharm. Inc. (11.20%),

Build a custom stock screener for Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lionco Pharmaceutical Group Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lionco Pharmaceutical Group Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Lionco Pharmaceutical Group Co.,Ltd.'s ROE?

How is the ROE calculated for Lionco Pharmaceutical Group Co.,Ltd. (603669.SS)?

What is the highest ROE for Lionco Pharmaceutical Group Co.,Ltd. (603669.SS)?

What is the 3-year average ROE for Lionco Pharmaceutical Group Co.,Ltd. (603669.SS)?

What is the 5-year average ROE for Lionco Pharmaceutical Group Co.,Ltd. (603669.SS)?

How does the current ROE for Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) compare to its historical average?